Literature DB >> 10573346

Ultrasound and neonatal hip screening: the five-year results of a prospective study in high-risk babies.

K Lewis1, D A Jones, N Powell.   

Abstract

We present the 5-year results of an ongoing prospective study of static ultrasound scanning for developmental dysplasia of the hip (DDH) to enlarge on and update the findings after the first year of this screening programme. Between January 1988 and December 1992, there were 17,792 births, 2,683 of which had risk factors: 354 babies had abnormal scans. Screening failed in eight cases, two of which were preventable because they had risk factors but were not scanned; however, six cases came from the 85% of babies without risk factors. The incidence of late cases is therefore 0.45 per thousand births. These results indicate that static ultrasound scanning is effective in detecting abnormal hips, but if only the "at risk" group is screened in this way, then there will be an expected rate of late cases of approximately 0.34/1,000. We are concerned with the results of screening (i.e., detection) but not management. We conclude that simple static ultrasound is an effective screening test for DDH but that it should be applied to the whole population and not simply to the "at risk" group.

Entities:  

Mesh:

Year:  1999        PMID: 10573346

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  9 in total

1.  Familial isolated clubfoot is associated with recurrent chromosome 17q23.1q23.2 microduplications containing TBX4.

Authors:  David M Alvarado; Hyuliya Aferol; Kevin McCall; Jason B Huang; Matthew Techy; Jillian Buchan; Janet Cady; Patrick R Gonzales; Matthew B Dobbs; Christina A Gurnett
Journal:  Am J Hum Genet       Date:  2010-07-09       Impact factor: 11.025

2.  Effectiveness of ultrasound screening for developmental dysplasia of the hip.

Authors:  E A Roovers; M M Boere-Boonekamp; R M Castelein; G A Zielhuis; T H Kerkhoff
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

3.  Diagnosing developmental dysplasia of the hip using the Graf ultrasound method: risk and protective factor analysis in 11,820 universally screened newborns.

Authors:  Mohammad Schams; Rob Labruyère; Anne Zuse; Mikolaj Walensi
Journal:  Eur J Pediatr       Date:  2017-07-17       Impact factor: 3.183

4.  Selective ultrasound screening for developmental hip dysplasia: effect on management and late detected cases. A prospective survey during 1991-2006.

Authors:  Lene Bjerke Laborie; Trond Jacob Markestad; Henrik Davidsen; Kari Røine Brurås; Stein Magnus Aukland; John Asle Bjørlykke; Hallvard Reigstad; Kari Indrekvam; Trude Gundersen Lehmann; Ingvild Øvstebø Engesæter; Lars Birger Engesæter; Karen Rosendahl
Journal:  Pediatr Radiol       Date:  2013-12-13

5.  The use of X-ray at 5 months in a selective screening programme for developmental dysplasia of the hip.

Authors:  Kathryn R Price; Rosemary Dove; James B Hunter
Journal:  J Child Orthop       Date:  2011-04-01       Impact factor: 1.548

6.  Performance, treatment pathways, and effects of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom.

Authors:  C Dezateux; J Brown; R Arthur; J Karnon; A Parnaby
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

7.  Efficiency of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom.

Authors:  J Brown; C Dezateux; J Karnon; A Parnaby; R Arthur
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

8.  [Hip ultrasound screening in Germany. Results and comparison with other screening procedures].

Authors:  N Ihme; L Altenhofen; R von Kries; F U Niethard
Journal:  Orthopade       Date:  2008-06       Impact factor: 1.004

9.  Disparity between Clinical and Ultrasound Examinations in Neonatal Hip Screening.

Authors:  Bong Soo Kyung; Soon Hyuck Lee; Woong Kyo Jeong; Si Young Park
Journal:  Clin Orthop Surg       Date:  2016-05-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.